Tag Archives: Eli Lilly

Abbott Shells Out $3.7 Billion for Piramal

In July 2009, judging solely by total revenue, Abbott was assigned the rank of the eighth-largest pharmaceutical company in the Fortune Global 500. Nearly a year later, the company is looking to move up at least a few notches. On May 21, Abbott acquired Indian generic giant Piramal for a cool $2.12 billion up front, […]
Posted in Strategy | Also tagged , , , , , , , , | Leave a comment

Lower Lilly Earnings the Shape of Things to Come

Eli Lilly announced its first quarter financial results on April 19. But even though the company trumpeted a global revenue growth rate of 9 percent—$5.49 billion, compared to Q1 2009’s $5.05 billion—net income fell 5 percent to $1.25 billion. Part of the blame for that 4 percent difference, the company said, lies with the passage […]
Posted in Strategy | Also tagged , , , , , | Leave a comment

Merck, Lilly, Pfizer: One for All and All for One

Just a month after Andrew Witty’s announcement that GSK will make more than 13,500 of its malaria compounds available to all, Pfizer, Merck, and Eli Lilly have thrown their do-gooder hats into the ring as well. Together, the three drug giants will pull together an undisclosed dollar amount in seed funding and create the independent, […]
Posted in Strategy | Also tagged , , , , , , | 1 Comment

HBA Names Woman of the Year

GSK’s Deirdre Connelly has been named the Healthcare Businesswomen’s Association’s Woman of the Year for 2010. Connelly, who just passed the one-year mark as president of GSK’s North American pharmaceuticals unit, is the 21st woman to win the organization’s “WOTY” award, which comes on the heels of another honor: She was ranked #37 in Fortune’s […]
Posted in Corporate Responsibility, leadership, News, People | Also tagged , , , | Leave a comment

The Trouble with Transparency

Guest blog by Jacky Law A couple of weeks ago I attended an industry awards dinner and had an interesting conversation with an eminent doctor who shall remain nameless. The doctor in question works in a highly specialized area and frequently talks about her research at conferences around the world. She always travels first-class and […]
Posted in Guest Blog, Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta